Ovoca Bio (STU:OVXA) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Ovoca Bio Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Ovoca Bio's net issuance of preferred for the six months ended in Jun. 2024 was €0.00 Mil. The number is 0, which means that Ovoca Bio has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Ovoca Bio's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Ovoca Bio Net Issuance of Preferred Stock Historical Data

The historical data trend for Ovoca Bio's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio Net Issuance of Preferred Stock Chart

Ovoca Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Ovoca Bio Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Ovoca Bio Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Ovoca Bio Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Ovoca Bio's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovoca Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (STU:OVXA) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

OVXA:Ireland OVB.GB:UK OVB:UK

Address

17 Pembroke Street Upper, Dublin, IRL, D02 AT22

Website

https://www.ovocabio.com

Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio Headlines

No Headlines